STERIS (STE) Stock Price, News & Analysis

Company Overview

STERIS plc is a global provider of infection prevention, contamination control and surgical support equipment and services headquartered in Dublin, Ireland, with major operations in Mentor, Ohio. The company develops and delivers a wide range of products and solutions designed to support the healthcare, pharmaceutical, medical device and research industries in maintaining clean and safe environments. Its core offerings include sterilization equipment, surgical instrumentation, single-use sterile products and comprehensive service and validation programs.

In its healthcare segment, STERIS supplies hospitals, ambulatory surgery centers and physician offices with steam and low-temperature sterilizers, endoscope reprocessing systems, surgical tables, lights and equipment management solutions. The life sciences and pharmaceutical segment addresses critical contamination control needs for drug and device manufacturers through cleanroom solutions, washer-disinfectors, isolators, safety-engineered stoppers, sealing systems and contract sterilization services for oxygen and hydrogen peroxide cycles.

Founded in 1985 as STERIS Corporation and later restructured as an Ireland-domiciled public limited company following the 2019 merger with UK-based Synergy Health, the firm has grown its footprint through strategic acquisitions and organic investment in research and development. Past acquisitions include Key Surgical, Integrated Medical Systems Corporation and Cantel Medical’s sterilization business. James P. Lawrence, appointed President and Chief Executive Officer in 2014, leads an executive team focused on innovation, regulatory compliance and global expansion.

STERIS operates in more than 25 countries with manufacturing facilities, service centers and distribution networks spanning North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. The company’s service organization delivers on-site maintenance, validation, asset management and training, while its global regulatory and quality teams support customers in meeting stringent regional and international standards.

Key Stats

• Today's Range: $238.20 to $243.08
• 50-Day Range: $222.23 to $252.31
• 52-Week Range: $200.98 to $252.79
• Volume: 918,422 shs
• Average Volume: 548,286 shs
• Market Capitalization: $23.83 billion
• P/E Ratio: 39.08
• Dividend Yield: 0.94%
• Price Target: $263.83
• Consensus Rating: Moderate Buy

STERIS Stock Analysis - MarketRank™

STERIS scored higher than 94% of companies evaluated by MarketBeat, and ranked 68th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

STERIS has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

STERIS has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.36%

Earnings Growth

Earnings for STERIS are expected to grow by 9.36% in the coming year, from $9.08 to $9.93 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of STERIS is 39.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.87.

Price to Earnings Ratio vs. Sector

The P/E ratio of STERIS is 39.08, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.25.

Price to Book Value per Share Ratio

STERIS has a P/B Ratio of 3.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.74% of the float of STERIS has been sold short.

Short Interest Ratio / Days to Cover

STERIS has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in STERIS has recently decreased by 19.05%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

STERIS has a dividend yield of 0.95%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

STERIS has been increasing its dividend for 20 years.

Dividend Coverage

The dividend payout ratio of STERIS is 36.77%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, STERIS will have a dividend payout ratio of 22.96% next year. This indicates that STERIS will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -2.00

Percentage of Shares Shorted

0.74% of the float of STERIS has been sold short.

Short Interest Ratio / Days to Cover

STERIS has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in STERIS has recently decreased by 19.05%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 1.23

News Sentiment

STERIS has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for STERIS this week, compared to 11 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, STERIS insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,483,389.00 in company stock.

Percentage Held by Insiders

Only 1.07% of the stock of STERIS is held by insiders.

Percentage Held by Institutions

94.69% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

STE Stock Analysis - Frequently Asked Questions

How have STE shares performed this year?

STERIS's stock was trading at $205.56 at the beginning of 2025. Since then, STE stock has increased by 17.9% and is now trading at $242.27.
View the best growth stocks for 2025 here.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) issued its quarterly earnings data on Wednesday, May, 14th. The medical equipment provider reported $2.74 EPS for the quarter, beating analysts' consensus estimates of $2.59 by $0.15. STERIS's revenue for the quarter was up 5.7% on a year-over-year basis.
Read the conference call transcript.

Who are STERIS's major shareholders?

Top institutional investors of STERIS include Kera Capital Partners Inc.. Insiders that own company stock include Daniel A Carestio, Michael J Tokich, Mohsen Sohi, Cary L Majors, Renato Tamaro and Jacqueline B Kosecoff.
View institutional ownership trends.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that STERIS investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Visa (V), Home Depot (HD) and Advanced Micro Devices (AMD).

Company Calendar

• Last Earnings: 5/14/2025
• Record date for 6/26 Dividend: 6/10/2025
• Ex-Dividend for 6/26 Dividend: 6/10/2025
• Dividend Payable: 6/26/2025
• Today: 7/02/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:STE
• CIK: 1757898
• Web: www.steris.com
• Phone: (440) 354-2600
• Fax: 440-639-4457
• Employees: 17,787
• Year Founded: 1987

Price Target and Rating

• Average Stock Price Target: $263.83
• High Stock Price Target: $280.00
• Low Stock Price Target: $250.00
• Potential Upside/Downside: +8.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.63
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $6.20
• Trailing P/E Ratio: 39.08
• Forward P/E Ratio: 26.68
• P/E Growth: N/A
• Net Income: $614.64 million
• Net Margins: 11.26%
• Pretax Margin: 14.58%
• Return on Equity: 14.21%
• Return on Assets: 9.13%

Debt

• Debt-to-Equity Ratio: 0.29
• Current Ratio: 1.96
• Quick Ratio: 1.39

Sales & Book Value

• Annual Sales: $5.46 billion
• Price / Sales: 4.37
• Cash Flow: $14.38 per share
• Price / Cash Flow: 16.85
• Book Value: $67.33 per share
• Price / Book: 3.60

Miscellaneous

• Outstanding Shares: 98,370,000
• Free Float: 97,318,000
• Market Cap: $23.83 billion
• Optionable: Optionable
• Beta: 0.92